Colin serves as both the Chief Technology Officer and Vice President. He provides technical, strategic, product development and manufacturing expertise to Singapore-based start-up companies. He helps them leverage technologies into transformative and viable devices in the medical and life science industries. Colin is also an Exemplar Global trained Quality Management Systems (ISO 13485:2016, 21-CFR-820) Lead Auditor.

Prior to joining KECOJO, Colin held various positions in his 17-year tenure at Medtronic Diabetes in the USA. He led research, development and manufacturing efforts for implantable and external insulin pumps, continuous glucose monitoring (CGM) hardware, and single-use, sterile disposable products. As Director of Global Technology Development, he strategically led internal, external and international cross functional teams to understand market segmentation, cost & feature sensitivity, and regulatory strategies. This included product teams in Europe, manufacturing operations in Asia, and quality, regulatory, marketing, finance and clinical evaluation teams in the USA.

Colin received his Bachelor’s and Master’s degrees in Mechanical Engineering from The Ohio State University in Columbus, Ohio.

Colin holds 50 US and corresponding international patents, and is a recipient of the President’s Award for Outstanding Innovation from Medtronic Diabetes.